Decreased regenerative capacity of oligodendrocyte progenitor cells (NG2-glia) in the ageing brain: A vicious cycle of synaptic dysfunction, myelin loss and neuronal disruption?

Current Alzheimer Research

Volumn 13, Issue 4, 2016, Pages 413-418

  Rivera, Andrea ^a   Vanzuli, Ilaria ^a   Arellano, José Julio Rodríguez ^b   Butt, Arthur ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Alzheimer s disease; Dementia; Glutamate. myelin; Oligodendrocyte; Oligodendrocyte progenitor; White matter

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID; MYELIN; NEUROTRANSMITTER; ANTIGEN; CHONDROITIN SULFATE PROTEOGLYCAN 4; PROTEOGLYCAN;

ALZHEIMER DISEASE; ARTICLE; BRAIN MATURATION; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; COGNITIVE DEFECT; DEMENTIA; DEREGULATION; HUMAN; MYELINATION; NEUROTRANSMISSION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; SYNAPSE; WHITE MATTER; AGING; ANIMAL; BRAIN; METABOLISM; MYELIN SHEATH; NERVE CELL; NERVE REGENERATION; PATHOLOGY; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; ANIMALS; ANTIGENS; BRAIN; HUMANS; MYELIN SHEATH; NERVE REGENERATION; NEURONS; OLIGODENDROGLIA; PROTEOGLYCANS; STEM CELLS;

EID: 84964009536     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205013666151116125518     Document Type: Article

References (59)

1. Kumar A, Cook IA. White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Dev Neurosci 24(4): 255-61 (2002).
2. Haroutunian V, Katsel P, Roussos P, Davis KL, Altshuler LL, Bartzokis G. Myelination, oligodendrocytes, and serious mental illness. Glia 62(11): 1856-77 (2014).
3. Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 58(5): 461-5 (2001).
4. Peters A, Sethares C. Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cereb Cortex 14(9): 995-1007 (2004).
5. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 11(12): p. 1392-401 (2008).
6. Sampaio-Baptista C, Khrapitchev AA, Foxley S, Schlagheck T, Scholz J, Jbabdi S, et al. Motor skill learning induces changes in white matter microstructure and myelination. J Neurosci 33(50): 19499-503.
7. Scholz J, Klein MC, Behrens TE, Johansen-Berg H. Training induces changes in white-matter architecture. Nat Neurosci 12(11): 1370-1 (2009).
8. Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, Attwell D, et al. Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77(5): 873-85 (2013).
9. Zhu X, Hill RA, Dietrich D, Komitova M, Suzuki R, Nishiyama A. Age-dependent fate and lineage restriction of single NG2 cells. Development 138(4): 745-53 (2011).
10. Richardson WD, Young KM, Tripathi RB, McKenzie I, et al., NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron 70(4): 661-73 (2011).
11. Dimou L, Simon C, Kirchhoff F, Takebayashi H, Gotz M. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci 28(41): 10434-42 (2008).
12. Zhu X, Hill RA, Nishiyama A. NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord. Neuron Glia Biol 4(1): 19-26 (2008).
13. Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68(4): 668-81 (2010).
14. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neurosci 30(48): 16383-90 (2010).
15. Guo F, Maeda Y, Ma J, Delgado M, Sohn J, Miers L, et al. Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis. J Neurosci 31(33): 11914-28 (2011).
16. Psachoulia K, Jamen F, Young KM, Richardson WD. Cell cycle dynamics of NG2 cells in the postnatal and ageing brain. Neuron Glia Biol 5(3-4): 57-67 (2009).
17. Simon C, Gotz M, Dimou L. Progenitors in the adult cerebral cortex: cell cycle properties and regulation by physiological stimuli and injury. Glia 59(6): 869-81 (2011).
18. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70(1): 9-14 (2001).
19. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 11(9): 1024-34 (2008).
20. Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3(9): 705-14 (2002).
21. Shields SA, et al. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxininduced CNS demyelination. Glia 28(1): 77-83 (1999).
22. Sim FJ, Zhao C, Penderis J, Franklin RJ. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22(7): 2451-9 (2002).
23. Fern RF, Matute C, Stys PK. White matter injury: Ischemic and nonischemic. Glia 62(11): 1780-9 (2014).
24. Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nature Neurosci 16(5): 571-9 (2013).
25. Bartzokis G, Lu PH, Mintz J. Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer’s disease. J Alzheimers Dis 6(6): S53-9 (2004).
26. Bowley MP, Cabral H, Rosene DL, Peters A. Age changes in myelinated nerve fibers of the cingulate bundle and corpus callosum in the rhesus monkey. J Comp Neurol 518(15): 3046-64 (2010).
27. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies. Acta Neuropathol 119(5): 579-89 (2010).
28. Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, Bowers WJ, et al. Triple-transgenic Alzheimer’s disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 57(1): 54-65 (2009).
29. Desai MK, Guercio BJ, Narrow WC, Bowers WJ. An Alzheimer’s disease-relevant presenilin-1 mutation augments amyloid-betainduced oligodendrocyte dysfunction. Glia 59(4): 627-40 (2011).
30. Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, Bowers WJ. Early oligodendrocyte/myelin pathology in Alzheimer’s disease mice constitutes a novel therapeutic target. Am J Pathol 177(3): 1422-35 (2010).
31. Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, et al. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer’s disease. Biochemistry 41(37): 11080-90 (2002).
32. Wake H, Lee PR, Fields RD. Control of local protein synthesis and initial events in myelination by action potentials. Science 333(6049): 1647-51 (2011).
33. Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, et al. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344(6183): 1252304 (2014).
34. Butt AM, Duncan A, Hornby MF, Kirvell SL, Hunter A, Levine JM, et al. Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter. Glia 26(1): 84-91 (1999).
35. Hamilton N, Vayro S, Wigley R, Butt AM. Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-glia. Glia 58(1): 66-79 (2010).
36. Bergles DE, Roberts JD, Somogyi P, Jahr CE. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405(6783): 187-91 (2000).
37. Kukley M, Capetillo-Zarate E, Dietrich D. Vesicular glutamate release from axons in white matter. Nat Neurosci 10(3): 311-20 (2007).
38. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10(3): 321-30 (2007).
39. Butt AM, Hamilton N, Hubbard P, Pugh M, Ibrahim M. Synantocytes: the fifth element. J Anat 207(6): 695-706 (2005).
40. Alix JJ, Dolphin AC, Fern R. Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation. J Physiol 586(Pt 17): 4069-89 (2008).
41. Barres BA, Raff MC. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 361(6409): 258-60 (1993).
42. Li Q, Brus-Ramer M, Martin JH, McDonald JW. Electrical stimulation of the medullary pyramid promotes proliferation and differentiation of oligodendrocyte progenitor cells in the corticospinal tract of the adult rat. Neurosci Lett 479(2): 128-33 (2010).
43. Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, et al. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci USA 93(18): 9887-92 (1996).
44. Stys PK. The axo-myelinic synapse. Trends Neurosci 34(8): 393-400 (2011).
45. Etxeberria A, Mangin JM, Aguirre A, Gallo V., Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat Neurosci 13(3): 287-9 (2010).
46. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39(3): 409-21 (2003).
47. Butt AM, Fern FR, Matute C. Neurotransmitter signaling in white matter. Glia 62(11): 1762-79 (2014).
48. Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol 65(6): 592-601 (2006).
49. Verkhratsky A, Butt, AM. Glial Physiology and Pathophysiology. Chichester: Wiley; 2013.
50. Vanzulli I, Rivera A, Butt AM. A central role for glial ATP signalling in CNS pathology. Curr Drug Targ (2015).
51. Yuan X, Eisen AM, McBain CJ, Gallo V. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125(15): 2901-14 (1998).
52. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438(7071): 1162-6 (2005).
53. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439(7079): 988-92 (2006).
54. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438(7071): 1167-71 (2005).
55. Boda E, Di Maria S, Rosa P, Taylor V, Abbracchio MP, Buffo A. Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors. Glia 63(2): 271-86 (2014).
56. Nielsen HM, Ek D, Avdic U, Orbjorn C, Hansson O, Netherlands BB, et al. NG2 cells, a new trail for Alzheimer’s disease mechanisms? Acta Neuropathol Commun 1(1): 7 (2013).
57. Lacor PN. Advances on the understanding of the origins of synaptic pathology in AD. Curr Genomics 8(8): 486-508 (2007).
58. Chakroborty S, Kim J, Schneider C, Jacobson C, Molgo J, Stutzmann GE. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer’s disease mice. J Neurosci 32(24): 8341-53 (2012).
59. Lipton SA. The molecular basis of memantine action in Alzheimer’s disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2(2): 155-65 (2005).